Tivic Health Systems Inc
TIVC1.890USD
0.000
Close 12/24, 13:00（ET）Quotes delayed by 15 min
3.14MMarket Cap
LossP/E TTM
More Details of Tivic Health Systems Inc Company
Tivic Health Systems, Inc. is a diversified therapeutics company, with complementary bioelectronic and biologic product candidates in its clinical pipeline. It harnesses the power of the immune and autonomic nervous systems to fight disease and restore health. It takes a multi-pronged approach to treating diseases caused by immune dysregulation and dysautonomia. The complement of bioelectronic and biologic medicines allows it to target disorders and disease via both neural pathways and molecular approaches. Its commercial product, ClearUP, is clinically proven to treat sinus pain and pressure. ClearUP is available through online retailers and commercial distributors. It also has worldwide exclusive license rights to the late-stage Toll-like Receptor 5 (TLR5) agonist Entolimod for the treatment of acute radiation syndrome (ARS). In addition, it has an exclusive option to license five additional indications and clinical use cases for Entolimod and its derivative, Entalasta.
Tivic Health Systems Inc Info
Ticker SymbolTIVC
Company nameTivic Health Systems Inc
IPO dateNov 11, 2021
CEOErnst (Jennifer)
Number of employees7
Security typeOrdinary Share
Fiscal year-endNov 11
Address47685 Lakeview Blvd
CityFREMONT
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94538
Phone18882766888
Websitehttps://tivichealth.com/
Ticker SymbolTIVC
IPO dateNov 11, 2021
CEOErnst (Jennifer)
Company Executives of Tivic Health Systems Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Jennifer Ernst
Ms. Jennifer Ernst
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
23.25K
+3192.78%
Ms. Lisa Wolf
Ms. Lisa Wolf
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Michael K. Handley
Mr. Michael K. Handley
Chief Operating Officer and President of Tivic Biopharma
Chief Operating Officer and President of Tivic Biopharma
--
--
Ms. Christina Valauri
Ms. Christina Valauri
Independent Director
Independent Director
--
--
Mr. Dean Zikria
Mr. Dean Zikria
Independent Director
Independent Director
--
--
Mr. Jim Hock
Mr. Jim Hock
Investor Relations
Investor Relations
--
--
Ms. Sheryle J Bolton
Ms. Sheryle J Bolton
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Jennifer Ernst
Ms. Jennifer Ernst
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
23.25K
+3192.78%
Ms. Lisa Wolf
Ms. Lisa Wolf
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Michael K. Handley
Mr. Michael K. Handley
Chief Operating Officer and President of Tivic Biopharma
Chief Operating Officer and President of Tivic Biopharma
--
--
Ms. Christina Valauri
Ms. Christina Valauri
Independent Director
Independent Director
--
--
Mr. Dean Zikria
Mr. Dean Zikria
Independent Director
Independent Director
--
--
Mr. Jim Hock
Mr. Jim Hock
Investor Relations
Investor Relations
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Dec 24
Updated: Wed, Dec 24
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Avenue Capital Group
5.76%
Statera BioPharma, Inc
3.47%
DRW Securities, LLC
3.05%
Avenue Venture Opportunities Fund LP
2.84%
Marex Group plc
2.17%
Other
82.71%
Shareholders
Shareholders
Proportion
Avenue Capital Group
5.76%
Statera BioPharma, Inc
3.47%
DRW Securities, LLC
3.05%
Avenue Venture Opportunities Fund LP
2.84%
Marex Group plc
2.17%
Other
82.71%
Shareholder Types
Shareholders
Proportion
Corporation
6.30%
Investment Advisor/Hedge Fund
6.04%
Investment Advisor
5.38%
Individual Investor
1.37%
Research Firm
0.08%
Other
80.82%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
22
44.96K
2.86%
+5.91K
2025Q2
32
112.57K
10.82%
+62.79K
2025Q1
32
1.24K
0.18%
-48.58K
2024Q4
34
288.82K
2.82%
-516.93K
2024Q3
32
301.13K
4.87%
-468.33K
2024Q2
32
639.36K
10.34%
+419.46K
2024Q1
34
88.08K
6.01%
-141.85K
2023Q4
34
75.33K
5.40%
-149.34K
2023Q3
33
160.42K
18.20%
+130.18K
2023Q2
33
60.32K
19.16%
+13.93K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Statera BioPharma, Inc
61.20K
3.89%
+61.20K
--
May 14, 2025
Avenue Venture Opportunities Fund LP
50.13K
3.18%
+50.13K
--
May 14, 2025
Marex Group plc
39.28K
2.5%
+39.28K
--
Jun 30, 2025
Ernst (Jennifer)
23.25K
1.48%
+22.54K
+3192.78%
Sep 22, 2025
Geode Capital Management, L.L.C.
--
0%
-2.15K
-100.00%
Mar 31, 2025
UBS Financial Services, Inc.
5.65K
0.36%
+5.65K
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Mar 05, 2025
Merger
17→1
Mar 05, 2025
Merger
17→1
Mar 05, 2025
Merger
17→1
Mar 05, 2025
Merger
17→1
Aug 22, 2023
Merger
100→1
Aug 22, 2023
Merger
100→1
Date
Type
Ratio
Mar 05, 2025
Merger
17→1
Mar 05, 2025
Merger
17→1
Mar 05, 2025
Merger
17→1
Mar 05, 2025
Merger
17→1
Aug 22, 2023
Merger
100→1
Aug 22, 2023
Merger
100→1
Aug 22, 2023
Merger
100→1
Aug 22, 2023
Merger
100→1
FAQs
Who are the top five shareholders of Tivic Health Systems Inc?
The top five shareholders of Tivic Health Systems Inc are:
Statera BioPharma, Inc holds 61.20K shares, accounting for 3.89% of the total shares.
Avenue Venture Opportunities Fund LP holds 50.13K shares, accounting for 3.18% of the total shares.
Marex Group plc holds 39.28K shares, accounting for 2.50% of the total shares.
Ernst (Jennifer) holds 23.25K shares, accounting for 1.48% of the total shares.
Geode Capital Management, L.L.C. holds 0.00 shares, accounting for 0.00% of the total shares.
Statera BioPharma, Inc holds 61.20K shares, accounting for 3.89% of the total shares.
Avenue Venture Opportunities Fund LP holds 50.13K shares, accounting for 3.18% of the total shares.
Marex Group plc holds 39.28K shares, accounting for 2.50% of the total shares.
Ernst (Jennifer) holds 23.25K shares, accounting for 1.48% of the total shares.
Geode Capital Management, L.L.C. holds 0.00 shares, accounting for 0.00% of the total shares.
What are the top three shareholder types of Tivic Health Systems Inc?
The top three shareholder types of Tivic Health Systems Inc are:
Avenue Capital Group
Statera BioPharma, Inc
DRW Securities, LLC
Avenue Capital Group
Statera BioPharma, Inc
DRW Securities, LLC
How many institutions hold shares of Tivic Health Systems Inc (TIVC)?
As of 2025Q3, 22 institutions hold shares of Tivic Health Systems Inc, with a combined market value of approximately 44.96K, accounting for 2.86% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -7.96%.
What is the biggest source of revenue for Tivic Health Systems Inc?
In --, the -- business generated the highest revenue for Tivic Health Systems Inc, amounting to -- and accounting for --% of total revenue.
